As of 2025-11-13, the Relative Valuation of E-Therapeutics PLC (ETX.L) is (34.96) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 9.00 GBP, the upside of E-Therapeutics PLC based on Relative Valuation is -488.5%.
The range of the Relative Valuation is (16.82) - (40.86) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 49.8x | 31.2x |
| Forward P/E multiples | 12.5x - 30.9x | 21.7x |
| Fair Price | (16.82) - (40.86) | (34.96) |
| Upside | -286.9% - -554.0% | -488.5% |
| Date | P/E |